Samelson-Jones, B. J. Ex vivo lentiviral gene therapy for severe hemophilia A: An alternative to recombinant adeno-associated viral-based strategies? Elsevier.
Chicago Style (17th ed.) CitationSamelson-Jones, Benjamin J. Ex vivo Lentiviral Gene Therapy for Severe Hemophilia A: An Alternative to Recombinant Adeno-associated Viral-based Strategies? Elsevier.
MLA (9th ed.) CitationSamelson-Jones, Benjamin J. Ex vivo Lentiviral Gene Therapy for Severe Hemophilia A: An Alternative to Recombinant Adeno-associated Viral-based Strategies? Elsevier.
Warning: These citations may not always be 100% accurate.